Capital planning for facilities under thin-margin constraints

The practical consequence: a hospital cannot fund a $5 million project from retained earnings the way a high-margin tech firm might. It borrows. And borrowing is where the real constraints live.

The three gates before the clinical case

Before the cath lab expansion reaches a full financial return analysis, it must clear three gates.

Gate 1: Debt covenants

Most hospital debt (often tax-exempt municipal bonds) comes with covenants: promises to bondholders that the borrower will maintain certain financial ratios. Break a covenant and the hospital can face penalties, forced refinancing, or a downgraded credit rating that raises the cost of all future borrowing.

Two covenants matter most for capital planning:

Debt service coverage ratio (DSCR). This measures whether cash flow covers annual debt payments. A common formula:

Bond agreements often require a DSCR of at least 1.10 to 1.25. If the hospital is already near that floor, adding new debt for the cath lab could push it below the line. That alone can kill the project regardless of clinical demand.

Days cash on hand (see Gate 2).

Gate 2: Days cash on hand

Days cash on hand (DCOH) measures how many days the organization could operate using only its unrestricted cash, assuming no new revenue came in.

Rating agencies and lenders watch this closely. As a rough benchmark, stronger investment-grade systems often hold 150 or more days, while stressed hospitals may sit well below 100. A big cash purchase, or a covenant that requires maintaining minimum DCOH, constrains how much cash the hospital can spend upfront.

For the cath lab, this means the CFO cannot drain reserves to avoid borrowing. Doing so could trip the DCOH covenant and trigger the same downgrade cascade.

Gate 3: Volume projections

The clinical team says demand is high. Finance needs that translated into defensible procedure volume and payer mix (the breakdown of patients by insurance type, which determines actual reimbursement).

This is where optimism gets tested. A new cath lab justified by "we're always full" needs numbers:

• How many procedures per year, ramping over time?
• What share is Medicare versus commercial insurance? Commercial typically pays more.
• How much is genuinely new volume versus procedures shifted from an existing lab (which adds cost without adding revenue)?

If half the projected volume is just moved from an underused existing room, the incremental return collapses.

Working the numbers: an illustrative walkthrough

Let us run a simplified, illustrative example. These figures are hypothetical and meant to show the logic, not real benchmarks.

Assume the expansion costs $5 million, financed with debt at a fixed rate. Suppose it adds 800 new procedures per year at maturity, with a blended contribution margin (revenue minus direct variable cost) of $2,500 per procedure.

Annual incremental contribution: 800 x $2,500 = $2,000,000.

From this, subtract new fixed costs: added staff, service contracts, and supplies overhead. Say those run $900,000 per year.

Incremental operating income: $2,000,000 - $900,000 = $1,100,000.

Now the debt service. On a $5 million loan amortized over the equipment's useful life, annual principal and interest might run, say, $650,000 (rate and term dependent).

Coverage on this project alone: roughly $1,100,000 available against $650,000 owed, or about 1.7x. That looks healthy in isolation.

But covenants apply to the whole system, not one project. If the system's overall DSCR is already at 1.15 against a 1.10 floor, the CFO must confirm the consolidated ratio stays above the line after adding this debt. A single strong project can still fail if the balance sheet has no room.

The sensitivity that decides it

The number that keeps CFOs awake is the ramp. What if volume hits only 60% of projection in year one?

• Contribution: 480 x $2,500 = $1,200,000, minus most of the $900,000 fixed cost that shows up immediately, leaving roughly $300,000.
• Against $650,000 in debt service, the project is underwater in year one.

Fixed costs arrive on day one. Volume ramps slowly. The gap between them is the risk. Good capital planning models the ramp explicitly and asks: can the system absorb the shortfall during ramp-up without breaching a covenant or draining DCOH below its floor?

For a primer on how these financial statements connect, the AHA and public resources like Investopedia's overview of debt service coverage ratio explain the mechanics clearly.

Structuring the decision under constraint

When margins and covenants leave no slack, CFOs rarely face a clean yes or no. They restructure the deal.

Phased capital. Buy the core equipment now, defer the second procedure room until volume proves out. This lowers upfront debt and protects DCOH.

Equipment leasing. Operating leases can keep some obligations off the balance sheet in ways that soften ratio impacts, though accounting rules (ASC 842) now bring most leases onto the books. Leasing still smooths cash outflow versus a lump purchase.

Vendor financing or risk-sharing. Some equipment makers offer usage-based or deferred payment terms, shifting ramp risk partly to the vendor.

Philanthropy and grants. Non-profit systems can fund capital through donor campaigns, reducing the debt component entirely. A named cardiac center is a common fundraising vehicle.

Ranking against other projects

The cath lab does not compete against a blank calendar. It competes against every other capital request: the aging MRI, the electronic health record upgrade, roof repairs that are not optional.

With limited borrowing capacity, capital planning becomes ranking. Common tiebreakers:

• Regulatory or safety mandates win automatically (you must replace failing fire systems).
• Strategic service lines with strong payer mix rank high.
• Return per dollar of scarce capital matters more than raw return, because the constraint is capital itself.

A cath lab with a 1.7x standalone coverage might still lose to a smaller project with a faster ramp and lower covenant risk.

Key takeaways

• Margins gate everything. With operating margins under 3%, hospitals fund major projects through debt, so lender covenants, not clinical demand, set the real ceiling on capital.
• Covenants apply system-wide. A strong standalone project can still fail if consolidated DSCR or days cash on hand sits too close to its floor. Always test the whole balance sheet.
• The ramp is the risk. Fixed costs hit immediately while volume builds slowly. Model conservative ramp scenarios and confirm the system can absorb early shortfalls.
• Volume projections need scrutiny. Separate genuinely new procedures from shifted ones, and pin down payer mix, because reimbursement, not procedure count, drives cash flow.
• Structure beats a binary yes or no. Phasing, leasing, vendor terms, and philanthropy let CFOs pursue needed capacity without breaching the financial constraints that protect the entire system.